Albert Bourla

Albert Bourla, Chief Executive Officer of US-based pharmaceutical giant Pfizer, encountered a series of tough questions about the efficacy of its Covid vaccine on the sidelines of the ongoing World Economic Forum meeting, but he repeatedly…

DAVOS: Albert Bourla, Chief Executive Officer of US-based pharmaceutical giant Pfizer, encountered a series of tough questions about the efficacy of its Covid vaccine on the sidelines of the ongoing World Economic Forum meeting, but he…

Pfizer CEO Albert Bourla at the World Economic Forum in Davos, Switzerland, on January 19, 2023. | Photo Credit: AP Pfizer's chief executive says the biggest challenge the company and other vaccine-makers faced during the pandemic was…

Pfizer Inc Chief Executive Officer Albert Bourla said on Saturday he had tested positive for COVID-19. "I'm feeling well and symptom free," Bourla said in a statement. Bourla, 60, back in August had contacted COVID and had started a course…

The United States regulators authorised a second booster dose of Pfizer Inc and BioNTech SE's Covid-19 vaccine for people 50 and older due to concerns about waning immunity in the age group, the drugmakers said on Tuesday. The U.S. Food…

Pfizer Inc said on Tuesday it expects 2022 sales of its Covid-19 vaccine and antiviral pill to top $54 billion, but that fell short of lofty Wall Street estimates and its shares were off about 3%.Still, Chief Executive Albert Bourla said…

WASHINGTON: United States pharmaceutical company Pfizer on Tuesday asked regulators to authorise its Covid pill after it was shown to cut hospitalisation or death by nearly 90% among newly infected high-risk patients. The move comes a few…

Pfizer Inc and BioNTech SE said on Monday their Covid-19 vaccine induced a robust immune response in 5 to 11 year olds, and they plan to ask for regulatory authorization as soon as possible to use the shot in children in that age range in…